David Badcock's guest appearances

David Badcock

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

Professionally Cannabis & Psychedelics

Fascinate Pod

Nikolay Tretiyakov

Max Simon

Bruce Linton

Dedi Meiri

Aras Azadian

Mark Reinders

Tjalling Erkelens

Raphael Mechoulam

Tim Phillips

Bek Muslimov

Mitchell Osak

Tyler Robson

Deepak Anand

Tim Shu

Tej Virk

OwlTail

How important is patient data to show the efficacy of medical cannabis?This week we’re joined by Prof. David Nutt and David Badcock - from Drug Science - the UK’s leading independent scientific body on drugs.This week, we explore Drug Science’s newest observational study - Project Twenty21. We explore its aims to change the way medical cannabis is perceived and prescribed in the UK, it’s operations, and the challenges of data collection on such a large project.Learn more about Project Twenty21 here: https://drugscience.org.uk/twenty21-is-now-live/→ View full show notes and summary here: https://www.canverse.global/shownotes/episode-81-drug-science-and-project-twenty21-with-prof-david-nutt-chair-of-the-scientific-committee-and-david-badcock-ceo-of-drug-scienceAbout David BadcockDavid Badcock is the Chief Executive Officer of Drug Science, the leading independent scientific body on drugs in the UK, working to provide clear, evidence-based information without political or commercial interference. Previously David held strategic positions in the substance misuse treatment sector for over 15 years. During this time, he has met and worked with thousands of individuals who have turned their lives around to lead healthy, successful lives free from the burden of drug addiction. He was previously the Chief Executive Officer of Mainliners, a national drug treatment organisation focusing on harm reduction and blood borne viruses.  David has been a committee member for the Cambridge Ethnic Community Forum, Chair of The Alliance (supporting people who receive prescribed medication for drug dependency), and Scientific Committee member for the influential London Joint Working Group for Substance Misuse and Hepatitis C. David specialises in creating unique partnerships with organisations and companies who share a joint vision to help the most marginalised and vulnerable members of our communities.About Professor David NuttProfessor David Nutt is the Edmond J. Safra Professor of Neuropsychopharmacology in the Division of Brain Sciences, Imperial College London. He has published over 400 original research papers, 8 government reports on drugs and 31 books, including one for the general public, Drugs: without the hot air, winning the Transmission Prize in 2014. He was formerly the President of the European Brain Council and is the founding Chair of DrugScience. Professor Nutt broadcasts widely to the general public both on radio and television. In 2010, The Times Eureka science magazine voted him one of the 100 most important figures in British ScienceQuotablesIn reality, medicine is about trying things out in patients 24:58Doctors are scared of doing anything they haven’t been taught to do… there is nothing in medical school curriculum about medical cannabis 10:52The problem with medical cannabis in the UK… is getting doctors to accept it does work 13:00ResourcesDrug Science Website: https://drugscience.org.uk/Drug Science Wikipedia Page: https://en.wikipedia.org/wiki/DrugScienceFollow Drug Science on LinkedIn: https://www.linkedin.com/company/drugscience-ltdFollow Drug Science on Twitter: https://twitter.com/Drug_Science?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5EauthorFollow Prof. David Nutt on Twitter: https://twitter.com/ProfDavidNutt&lt;

How important is patient data to show the efficacy of medical cannabis?This week we’re joined by Prof. David Nutt and David Badcock - from Drug Science - the UK’s leading independent scientific body on drugs.This week, we explore Drug Science’s newest observational study - Project Twenty21. We explore its aims to change the way medical cannabis is perceived and prescribed in the UK, it’s operations, and the challenges of data collection on such a large project.Learn more about Project Twenty21 here: <a href="https://drugscience.org.uk/twenty21-is-now-live/" rel="nofollow" target="_blank">https://drugscience.org.uk/twenty21-is-now-live/</a> → View full show notes and summary here: <a href="https://www.canverse.global/shownotes/episode-81-drug-science-and-project-twenty21-with-prof-david-nutt-chair-of-the-scientific-committee-and-david-badcock-ceo-of-drug-science" rel="nofollow" target="_blank">https://www.canverse.global/shownotes/episode-81-drug-science-and-project-twenty21-with-prof-david-nutt-chair-of-the-scientific-committee-and-david-badcock-ceo-of-drug-science</a> About David BadcockDavid Badcock is the Chief Executive Officer of Drug Science, the leading independent scientific body on drugs in the UK, working to provide clear, evidence-based information without political or commercial interference. Previously David held strategic positions in the substance misuse treatment sector for over 15 years. During this time, he has met and worked with thousands of individuals who have turned their lives around to lead healthy, successful lives free from the burden of drug addiction. He was previously the Chief Executive Officer of Mainliners, a national drug treatment organisation focusing on harm reduction and blood borne viruses.  David has been a committee member for the Cambridge Ethnic Community Forum, Chair of The Alliance (supporting people who receive prescribed medication for drug dependency), and Scientific Committee member for the influential London Joint Working Group for Substance Misuse and Hepatitis C. David specialises in creating unique partnerships with organisations and companies who share a joint vision to help the most marginalised and vulnerable members of our communities. About Professor David NuttProfessor David Nutt is the Edmond J. Safra Professor of Neuropsychopharmacology in the Division of Brain Sciences, Imperial College London. He has published over 400 original research papers, 8 government reports on drugs and 31 books, including one for the general public, Drugs: without the hot air, winning the Transmission Prize in 2014. He was formerly the President of the European Brain Council and is the founding Chair of DrugScience. Professor Nutt broadcasts widely to the general public both on radio and television. In 2010, The Times Eureka science magazine voted him one of the 100 most important figures in British Science QuotablesIn reality, medicine is about trying things out in patients 24:58Doctors are scared of doing anything they haven’t been taught to do… there is nothing in medical school curriculum about medical cannabis 10:52The problem with medical cannabis in the UK… is getting doctors to accept it does work 13:00 ResourcesDrug Science Website: <a href="https://drugscience.org.uk/" rel="nofollow" target="_blank">https://drugscience.org.uk/</a>Drug Science Wikipedia Page: <a href="https://en.wikipedia.org/wiki/DrugScience" rel="nofollow" target="_blank">https://en.wikipedia.org/wiki/DrugScience</a>Follow Drug Science on LinkedIn: <a href="https://www.linkedin.com/company/drugscience-ltd" rel="nofollow" target="_blank">https://www.linkedin.com/company/drugscience-ltd</a>Follow Drug Science on Twitter: <a href="https://twitter.com/Drug_Science?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor" rel="nofollow" target="_blank">https://twitter.com/Drug_Science?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor</a>Follow Prof. David Nutt on Twitter: <a href="https://twitter.com/ProfDavidNutt" rel="nofollow" target="_blank">https://twitter.com/ProfDavidNutt</a> &lt;

EPISODE #81 Drug Science and Project Twenty21 with Prof. David. Nutt (Chair of The Scientific Committee) and David Badcock (CEO) of Drug Science

Tune in to this week's episode of the Professionally Cannabis Podcast to hear exclusive insights today from David Badcock, CEO at Drug Science. As CEO of the charity spearheading Project Twenty21 – the initiative aiming to get cannabis medicine to 20,000 patients in the UK – David explores the UK cannabis landscape, the team behind Drug Science, and other projects around alcohol and psychedelics. Take a look at the full collection of podcasts and explore additional cannabis &amp; psychedelics content at: https://contenthub.gcintelligence.com/

Tune in to this week's episode of the Professionally Cannabis Podcast to hear exclusive insights today from David Badcock, CEO at Drug Science. As CEO of the charity spearheading Project Twenty21 – the initiative aiming to get cannabis medicine to 20,000 patients in the UK – David explores the UK cannabis landscape, the team behind Drug Science, and other projects around alcohol and psychedelics. Take a look at the full collection of podcasts and explore additional cannabis &amp; psychedelics content at: <a href="https://contenthub.gcintelligence.com/" rel="nofollow" target="_blank">https://contenthub.gcintelligence.com/</a>

David Badcock, CEO of Drug Science

CEO of Drug Science, The Independent Scientific Committee on Drugs, discusses the effect our current drug policy is having and why it needs to be changed to a policy backed by evidence. Useful links:Drug Science - http://www.drugscience.org.uk/Clark French - https://www.youtube.com/watch?v=J61tDSa76ao&amp;t=18sProf. David Nutt - https://twitter.com/ProfDavidNutt A Framework for a regulated market for cannabis in the UK- https://www.tdpf.org.uk/sites/default/files/A_framework_for_a_regulated_market_for_cannabis_in_the_UK.pdfA Fascinate Productions podcast

CEO of Drug Science, The Independent Scientific Committee on Drugs, discusses the effect our current drug policy is having and why it needs to be changed to a policy backed by evidence. Useful links:Drug Science - <a href="http://www.drugscience.org.uk/" rel="noopener noreferrer nofollow" target="_blank">http://www.drugscience.org.uk/</a>Clark French - <a href="https://www.youtube.com/watch?v=J61tDSa76ao&amp;t=18s" rel="noopener noreferrer nofollow" target="_blank">https://www.youtube.com/watch?v=J61tDSa76ao&amp;t=18s</a>Prof. David Nutt - <a href="https://twitter.com/ProfDavidNutt" rel="noopener noreferrer nofollow" target="_blank">https://twitter.com/ProfDavidNutt</a> A Framework for a regulated market for cannabis in the UK- <a href="https://www.tdpf.org.uk/sites/default/files/A_framework_for_a_regulated_market_for_cannabis_in_the_UK.pdf" rel="noopener noreferrer nofollow" target="_blank">https://www.tdpf.org.uk/sites/default/files/A_framework_for_a_regulated_market_for_cannabis_in_the_UK.pdf</a>A <a href="https://fascinateproductions.co.uk/" rel="noopener noreferrer nofollow" target="_blank">Fascinate Productions</a> podcast

7. David Badcock - Drug policy reform. What does the evidence say?